CHPA Pegs Consumer Devices, Dietary Supplements As Key Priorities

The over-the-counter drug lobby will broaden its focus to include consumer medical devices, and it plans to work with FDA to establish a definition and standards separate from those used to regulate more traditional medical devices, the Consumer Healthcare Products Association told Inside Health Policy. The organization also will increase its focus on dietary supplements, including those containing cannabidiol (CBD). As CHPA expands its focus in 2020, it plans to work with its members, FDA and Congress to ensure...